Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver

Hepatology

Volumn 28, Issue 1, 1998, Pages 86-89

  Aihara, Tomohiko ^a,b   Noguchi, Shinzaburo ^a   Miyoshi, Yasuo ^b   Nakano, Hiroshi ^a   Sasaki, Yo ^a   Nakamura, Yusuke ^b   Monden, Morito ^b   Imaoka, Shingi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SOMATOMEDIN B;

ALLELE; ARTICLE; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER NODULE; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; REFERENCE VALUES; TRANSCRIPTION, GENETIC;

EID: 0031835594     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280113     Document Type: Article

References (20)

1. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, et al. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996;271:11477-11483.
2. Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z. Overexpression of the insulin-like growth factor-I receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 1996;56:1761-1765.
3. Neely EK, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol 1991;96:104-110.
4. Lamonerie T, Lavialle C, Haddada H, Brison O. IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 1995;61:587-592.
5. Suzuki H, Veda R, Takahashi T, Takahashi T. Altered imprinting in lung cancer. Nat Genet 1994;6:332-333.
6. Yballe CM, Vu TH, Huffman AR. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. J Clin Endocrinol Metab 1996;81:1607-1612.
7. Mori M, Inoue H, Shiraishi T, Mimori K, Shibuta K, Nakashima H, Mafune K, et al. Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer. Int J Cancer 1996;68:441-446.
8. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747-749.
9. Ogawa Q, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-751.
10. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomelhylation of H19. Oncogene 1996;12:423-430.
11. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet 1993;5:74-78.
12. Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, Nishio M, Osada H, et al. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 1996;12:1589-1592.
13. Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 1988;48:6844-6849.
14. Tadokoro K, Fujii H, Inoue T, Yamada M. Polymerase chain reaction for detection of ApaI polymorphism at the insulin like growth factor II gene. Nucleic Acids Res 1991;19:6967.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. International Working Party. Terminology of nodular hepatocellular lesions. HEPATOLOGY 1995;22:983-993.
17. Edmondson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
18. Vu TH, Hoffman AR. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 1994;371:714-717.
19. Nardone G, Romano M, Calabro A, Pedone PV, de-Sio I, Persico M, Budillon G, et al. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HEPATOLOGY 1996;23:1304-1312.
20. Li X, Nong Z, Elkström C, Larsson E, Nordlinder H, Hofmann WJ, Trautwein C, et al. Disrupted IGF2 promoter control by silencing of promoter PI in human hepatocellular carcinoma. Cancer Res 1997;57: 2048-2054.